We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
VAXELIS DTPa5-HB-IPV-Hib vaccine suspension for injection in 0.5 mL pre-filled syringe, Maxx Pharma Pty Ltd, CON-1270
Product name
VAXELIS DTPa5-HB-IPV-Hib vaccine suspension for injection in 0.5 mL pre-filled syringe
Sponsor name
Maxx Pharma Pty Ltd
ARTG
Batches
C24001 & C24007
Consent start
Consent no.
CON-1270
Duration
The consent is effective from 3 September 2024 until 3 September 2026.
Standard
subparagraph 8(1)(i) of Therapeutic Goods Order No. 91 - Standard for labels of prescription and related medicines
Non-compliance with standard
The syringe labels included in the product do not include the correct distributor name that has been approved by the TGA.
Conditions imposed
Import, Supply, &/or Export
import and supply
Therapeutic product type
Prescription medicines